Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.
Researchers have gained new insights into the genetic basis of rye reproduction. They have demonstrated how plants recombine ...
The award supports Schulman's efforts to create a programmable language for biomaterials that can bring us closer to making lab-grown organs and tissues ...
The national feature highlighted the story of Lindsey Rambo, the second participant in Opus Genetics’ ongoing Phase 1/2 trial of gene therapy OPGx-LCA5, aimed at restoring vision for people living ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
You should build responsible AI into every system from day one. These industry experts share proven ways to do it right.
Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.
diSArm clinical trial is that our phages injected intravenously can home in to the site of infection, penetrate biofilms, infect, and lyse S. aureus. Many deaths post flu, and most likely also ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback